(NASDAQ:TEM), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Tempus AI, Inc. (“Tempus” or “the Company”) (NASDAQ: TEM) and certain of its officers. Class Definition This lawsuit seeks to recover damages […]

(NASDAQ:PEPG), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against PepGen Inc. (“PepGen” or “the Company”) (NASDAQ: PEPG) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

(NYSE:VSTS), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Vestis Corporation (“Vestis” or “the Company”) (NYSE: VSTS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

(NYSE:DDD), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against 3D Systems Corporation (“3D Systems” or “the Company”) (NYSE: DDD) and certain of its officers. Class Definition This lawsuit seeks to recover

Programmatic Ad Seller Misrepresentation in Mobile Apps Q1 2025: Pixalate Estimates 35% of Global Open Programmatic Mobile App Ad Impressions Sold by Unauthorized Sellers According to Pixalate's latest Supply Path Optimization (SPO) research using SupplyChain Object (SCO) data, an estimated $3.15 billion in global CTV open programmatic ad spend is routed through unauthorized sellers; 9%

Vor Bio Report Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 01, 2025 CAMBRIDGE, Mass., July 01, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, effective as of June 26, 2025, the Board of Directors granted Jean-Paul Kress, the Company's Chief

CIVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Civitas Resources, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action

AAPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Apple Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit

WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class

VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit